Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective
Alesha Wale,1 Mark Ireland,2 Rowan Yemm,1 Sarah Hiom,3 Alison Jones,3 John Paul Spark,3 Mark Francis,4 Karen May,5 Louise Allen,5 Steve Ridd,6 Efi Mantzourani1,7 1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK; 2Community Pharmacy Wales, Cardiff, Wales, UK; 3S...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-08-01
|
Series: | Integrated Pharmacy Research and Practice |
Subjects: | |
Online Access: | https://www.dovepress.com/unlicensed-ldquospecialrdquo-medicines-understanding-the-community-pha-peer-reviewed-article-IPRP |
id |
doaj-9279d0af988a4555bb090c45e8ad9348 |
---|---|
record_format |
Article |
spelling |
doaj-9279d0af988a4555bb090c45e8ad93482020-11-25T02:42:30ZengDove Medical PressIntegrated Pharmacy Research and Practice2230-52542020-08-01Volume 99310456232Unlicensed “Special” Medicines: Understanding the Community Pharmacist PerspectiveWale AIreland MYemm RHiom SJones ASpark JPFrancis MMay KAllen LRidd SMantzourani EAlesha Wale,1 Mark Ireland,2 Rowan Yemm,1 Sarah Hiom,3 Alison Jones,3 John Paul Spark,3 Mark Francis,4 Karen May,5 Louise Allen,5 Steve Ridd,6 Efi Mantzourani1,7 1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK; 2Community Pharmacy Wales, Cardiff, Wales, UK; 3St. Mary’s Pharmaceutical Unit, Cardiff, Wales, UK; 4Swansea Bay University Health Board, Swansea, Wales, UK; 5Cardiff and Vale University Health Board, Swansea, Wales, UK; 6Mayberry Pharmacy, Cardiff, Wales, UK; 7NHS Wales Informatics Service, Cardiff, Wales, UKCorrespondence: Efi Mantzourani Email MantzouraniE1@cardiff.ac.ukObjective: Community pharmacy staff are responsible for obtaining and supplying unlicensed “special” medicines to patients in primary care. Less well-defined parameters for safe and effective use of unlicensed compared to licensed medicines, along with issues around maintaining consistency between care settings or among manufacturers, have been associated with increased risks. This study aimed to explore the views and experiences of community pharmacy staff on accessing and supplying unlicensed “special” medicines to patients in Wales and the perceived impact of challenges faced on patient care.Methods: A qualitative, phenomenological approach was employed, involving semi-structured interviews with pharmacists and pharmacy technicians working at one small chain of community pharmacies in Wales. The interview schedule focused on the personal experiences and perceptions of the participants on the processes involved in accessing and supplying unlicensed “special” medicines from a community pharmacy. Interviews were audio-recorded and transcribed verbatim.Results: A total of six participants completed the interview. Three main themes were constructed from inductive thematic analysis of the transcribed interviews: requirement for additional patient responsibilities; influences on the confidence felt by pharmacy staff when accessing and supplying unlicensed “special” medicines; and continuity of supply.Conclusion: This study gives a preliminary insight into the views and experiences of community pharmacy staff in Wales when accessing and supplying unlicensed “special” medicines. Further research is required to see if these views and experiences are representative of community pharmacy staff across the country.Keywords: unlicensed medicines, “special” medicines, specials, community pharmacy, transfer of care, medicines supply, transmural care, off-label, compoundinghttps://www.dovepress.com/unlicensed-ldquospecialrdquo-medicines-understanding-the-community-pha-peer-reviewed-article-IPRPunlicensed medicines‘special’ medicinesspecialscommunity pharmacytransfer of caremedicines supplytransmural careoff-labelcompounding. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wale A Ireland M Yemm R Hiom S Jones A Spark JP Francis M May K Allen L Ridd S Mantzourani E |
spellingShingle |
Wale A Ireland M Yemm R Hiom S Jones A Spark JP Francis M May K Allen L Ridd S Mantzourani E Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective Integrated Pharmacy Research and Practice unlicensed medicines ‘special’ medicines specials community pharmacy transfer of care medicines supply transmural care off-label compounding. |
author_facet |
Wale A Ireland M Yemm R Hiom S Jones A Spark JP Francis M May K Allen L Ridd S Mantzourani E |
author_sort |
Wale A |
title |
Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective |
title_short |
Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective |
title_full |
Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective |
title_fullStr |
Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective |
title_full_unstemmed |
Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective |
title_sort |
unlicensed “special” medicines: understanding the community pharmacist perspective |
publisher |
Dove Medical Press |
series |
Integrated Pharmacy Research and Practice |
issn |
2230-5254 |
publishDate |
2020-08-01 |
description |
Alesha Wale,1 Mark Ireland,2 Rowan Yemm,1 Sarah Hiom,3 Alison Jones,3 John Paul Spark,3 Mark Francis,4 Karen May,5 Louise Allen,5 Steve Ridd,6 Efi Mantzourani1,7 1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK; 2Community Pharmacy Wales, Cardiff, Wales, UK; 3St. Mary’s Pharmaceutical Unit, Cardiff, Wales, UK; 4Swansea Bay University Health Board, Swansea, Wales, UK; 5Cardiff and Vale University Health Board, Swansea, Wales, UK; 6Mayberry Pharmacy, Cardiff, Wales, UK; 7NHS Wales Informatics Service, Cardiff, Wales, UKCorrespondence: Efi Mantzourani Email MantzouraniE1@cardiff.ac.ukObjective: Community pharmacy staff are responsible for obtaining and supplying unlicensed “special” medicines to patients in primary care. Less well-defined parameters for safe and effective use of unlicensed compared to licensed medicines, along with issues around maintaining consistency between care settings or among manufacturers, have been associated with increased risks. This study aimed to explore the views and experiences of community pharmacy staff on accessing and supplying unlicensed “special” medicines to patients in Wales and the perceived impact of challenges faced on patient care.Methods: A qualitative, phenomenological approach was employed, involving semi-structured interviews with pharmacists and pharmacy technicians working at one small chain of community pharmacies in Wales. The interview schedule focused on the personal experiences and perceptions of the participants on the processes involved in accessing and supplying unlicensed “special” medicines from a community pharmacy. Interviews were audio-recorded and transcribed verbatim.Results: A total of six participants completed the interview. Three main themes were constructed from inductive thematic analysis of the transcribed interviews: requirement for additional patient responsibilities; influences on the confidence felt by pharmacy staff when accessing and supplying unlicensed “special” medicines; and continuity of supply.Conclusion: This study gives a preliminary insight into the views and experiences of community pharmacy staff in Wales when accessing and supplying unlicensed “special” medicines. Further research is required to see if these views and experiences are representative of community pharmacy staff across the country.Keywords: unlicensed medicines, “special” medicines, specials, community pharmacy, transfer of care, medicines supply, transmural care, off-label, compounding |
topic |
unlicensed medicines ‘special’ medicines specials community pharmacy transfer of care medicines supply transmural care off-label compounding. |
url |
https://www.dovepress.com/unlicensed-ldquospecialrdquo-medicines-understanding-the-community-pha-peer-reviewed-article-IPRP |
work_keys_str_mv |
AT walea unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT irelandm unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT yemmr unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT hioms unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT jonesa unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT sparkjp unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT francism unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT mayk unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT allenl unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT ridds unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective AT mantzouranie unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective |
_version_ |
1724773513670164480 |